Lupin Launches Generic Suprep® Bowel Prep Kit in the United States

News

Lupin Launches Generic Suprep® Bowel Prep Kit in the United States

 

 

 

Global pharma major Lupin Limited (Lupin) today announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States Food and Drug

Administration (FDA). Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Suprep® Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep® Bowel Prep Kit)
had estimated annual sales of USD 202 million in the U.S. (IQVIA MAT July 2022).

 

About Lupin

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The
Company develops and commercializes a wide range of branded and generic formulations, biotechnology
products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin
America (LATAM), Europe, and Middle East regions.

 

Bitcoin down 50%, due to China and Taiwan War

Related posts

Leave a Comment